Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials

Superior Outcome of Women With Stage I/II Cutaneous Melanoma: Pooled Analysis of Four European Organisation for Research and Treatment of Cancer Phase III Trials

(2012) Arjen Joosse et al.   JOURNAL OF CLINICAL ONCOLOGY

Sex Disparities in Cancer Mortality and Survival

(2011) M. B. Cook et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

(2011) Poulam M. Patel et al.   EUROPEAN JOURNAL OF CANCER

Estrogens, estrogen receptors and melanoma

(2011) Vincenzo De Giorgi et al.   Expert Review of Anticancer Therapy

Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria

(2011) Augustinus P.T. van der Ploeg et al.   JOURNAL OF CLINICAL ONCOLOGY

Does metastasectomy improve survival in patients with stage IV melanoma? a cancer registry analysis of outcomes

(2011) Nabil Wasif et al.   JOURNAL OF SURGICAL ONCOLOGY

Sex differences in survival of cutaneous melanoma are age dependent

(2011) Liljana Mervic et al.   MELANOMA RESEARCH

Melanoma and vitamin D

(2011) Sinead Field et al.   Molecular Oncology

The biology behind prognostic factors of cutaneous melanoma

(2010) Alan Spatz et al.   CURRENT OPINION IN ONCOLOGY

Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases

(2010) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

Gender Differences in 1,25 Dihydroxyvitamin D3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects

(2010) J. Correale et al.   JOURNAL OF IMMUNOLOGY

Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis

(2010) Arjen Joosse et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Gender aspects in skin diseases

(2010) W Chen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Reactive oxygen species and melanoma: an explanation for gender differences in survival?

(2010) Arjen Joosse et al.   Pigment Cell & Melanoma Research

Outcomes for Lymph Node-Positive Cutaneous Melanoma Over Two Decades

(2010) Steve R. Martinez et al.   WORLD JOURNAL OF SURGERY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY

The advantage of women in cancer survival: An analysis of EUROCARE-4 data

(2008) A. Micheli et al.   EUROPEAN JOURNAL OF CANCER

Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

(2008) Edward L. Korn et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

(2008) Alexander MM Eggermont et al.   LANCET